戻る Agenda
COVID-19, An Opportunity to Step Up International Collaboration
Session Chair(s)
Agnès Saint-Raymond, DrMed
Head of Division International Affairs
European Medicines Agency, Netherlands
COVID-19 pandemic followed closely the Nitrosamines crisis (emerging in 2018), affected multiples countries and regions, and required intensive international collaboration. We look back at what went well and what can be improved.
Learning Objective : Learning from 18 months of pandemic on the international collaboration, what has worked well and what can be improved. International collaboration on drug development and clinical trials, on emergency use, and on post approval monitoring of therapeutics.
Speaker(s)
Panelist
Pierre Sabourin, MBA
Health Canada, Canada
Assistant Deputy Minister, Health Products and Food Branch
Panelist
Emer Cooke, MBA, MSc
European Medicines Agency, Netherlands
Chair, ICMRA; Executive Director
Panelist
Deusdedit Mubangizi
WHO, Switzerland
Technical Officer, WHO Prequalification Program
Panelist
Yasuhiro Fujiwara, MD, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive
Panelist
Celia M. Witten, MD, PhD
FDA, United States
Deputy Director, Office of the Center Director, CBER